返回 
加入收藏
丹参酮ⅡA磺酸钠注射液治疗急性脑梗死的临床研究
x
请在关注微信后，向客服人员索取文件
| 篇名： | 丹参酮ⅡA磺酸钠注射液治疗急性脑梗死的临床研究 |
| TITLE： | |
| 摘要： | 目的：探讨丹参酮ⅡA磺酸钠注射液对急性脑梗死患者血清P-选择素、胶质纤维酸性蛋白（GFAP）和血管内皮生长因子（VEGF）及神经功能的影响。方法：选择2013年4月－2016年4月连云港市第一人民医院收治的急性脑梗死患者114例，按随机数字表法分为对照组与观察组，各57例。对照组患者给予常规治疗；观察组患者在对照组基础上加用丹参酮ⅡA磺酸钠注射液40 mg加入0.9％氯化钠注射液250 mL中，ivgtt，qd。7 d为1个疗程，两组均治疗2个疗程。比较两组患者治疗前和治疗7、14 d时的美国国立卫生院卒中量表（NIHSS）评分，血清P-选择素、GFAP和VEGF水平，以及不良反应发生情况。结果：治疗前，两组患者上述各项指标比较，差异均无统计学意义（P＞0.05）；与治疗前比较，两组患者治疗7、14 d时的NIHSS评分、血清P-选择素和GFAP水平均明显下降，血清VEGF水平明显上升，且治疗14 d时指标水平（NIHSS评分除外）均明显优于同组治疗7 d时，观察组指标水平均明显优于同期对照组，差异均有统计学意义（P＜0.05）。两组患者均未见明显不良反应发生。结论：丹参酮ⅡA磺酸钠注射液能显著降低急性脑梗死患者血清P-选择素和GFAP水平，提高VEGF水平，促进神经缺损功能恢复，且安全性较高。 |
| ABSTRACT： | OBJECTIVE： To investigate the effects of Tanshinone ⅡA sodium sulfonate injection on levels of P-selectin， glial fibrillary acidic protein （GFAP）， vascular endothelial growth factor （VEGF） and neurological function in patients with acute cerebral infarction. METHODS： A total of 114 patients with acute cerebral infarction selected from Lianyungang First People’s Hospital during Apr. 2013-Apr. 2016 were divided into control group and observation group according to random number table， with 57 cases in each group. Control group was given routine treatment. Observation group was additionally given Tanshinone ⅡA sodium sulfonate injection 40 mg 0.9％ sodium chlonride injection 250 mL， ivgtt， qd. A treatment course lasted for 7 d， and both received 2 courses of treatment. NIHSS scores， the levels of serum P-selectin， GFAP and VEGF were compared between 2 groups before treatment and after 7， 14 d of treatment. The occurrence of ADR was also compared. RESULTS： Before treatment， there was no statistical significance in above indexes between 2 groups （P＞0.05）. Compared to before treatment， NIHSS score， the levels of serum P-selectin and GFAP in 2 groups were decreased significantly after 7， 14 d of treatment， while the serum level of VEGF was increased significantly. These indexes of 2 groups after 14 d of treatment were significantly better than 7 d of treatment， except for NIHSS score. Above indexes of observation group was significantly better than those of control group during corresponding period， with statistical significance （P＜0.05）. No obvious ADR was found in 2 groups. CONCLUSIONS： For acute cerebral infarction， Tanshinone ⅡA sodium sulfonate injection can significantly reduce the levels of serum P-selectin and GFAP， improve VEGF level and promote the recovery of neurological damage with good safety. |
| 期刊： | 2017年第28卷第26期 |
| 作者： | 徐丙超，周芯羽，王轩，籍牛，董万利 |
| AUTHORS： | XU Bingchao，ZHOU Xinyu，WANG Xuan，JI Niu，DONG Wanli |
| 关键字： | 急性脑梗死；丹参酮ⅡA磺酸钠注射液；P-选择素；胶质纤维酸性蛋白；血管内皮生长因子；神经功能 |
| KEYWORDS： | Acute cerebral infarction； Tanshinone ⅡA sodium sulfonate injection； P-selectin； Glial fiber acidic protein； Vascular endothelial growth factor； Neurological function |
| 阅读数： | 641 次 |
| 本月下载数： | 2 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
